TECX Insider Trading

Insider Ownership Percentage: 9.20%
Insider Buying (Last 12 Months): $1,441,000.00
Insider Selling (Last 12 Months): $0.00

Tectonic Therapeutic Insider Trading History Chart

This chart shows the insider buying and selling history at Tectonic Therapeutic by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Tectonic Therapeutic Share Price & Price History

Current Price: $31.30
Price Change: Price Increase of +2.72 (9.52%)
As of 09/27/2024 12:05 PM ET

This chart shows the closing price history over time for TECX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Tectonic Therapeutic Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/26/2024Timothy A SpringerDirectorBuy50,000$28.82$1,441,000.003,796,764View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Tectonic Therapeutic (NASDAQ:TECX)

62.63% of Tectonic Therapeutic stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TECX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Tectonic Therapeutic Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2024Affinity Asset Advisors LLC58,331$0.96M0.1%N/A0.130%Search for SEC Filing on Google Icon
8/14/2024Farallon Capital Management LLC431,010$7.10M0.0%N/A0.960%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC89,029$1.47M0.0%N/A0.198%Search for SEC Filing on Google Icon
8/9/2024Atlas Venture Life Science Advisors LLC378,447$6.23M0.7%N/A0.843%Search for SEC Filing on Google Icon
8/6/2024Acadian Asset Management LLC109,629$1.80M0.0%N/A0.244%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Tectonic Therapeutic logo
Avrobio, Inc. is a bio-technology company. It develops step-change cell and gene therapies for the treatment of cancer and rare disease. The company operates primarily in the United States and Canada. Avrobio, Inc. is based in MA, United States.
Read More on Tectonic Therapeutic

Today's Range

Now: $31.30
Low: $29.61
High: $31.30

50 Day Range

MA: $18.32
Low: $16.06
High: $29.40

52 Week Range

Now: $31.30
Low: $12.12
High: $31.31

Volume

82,491 shs

Average Volume

35,249 shs

Market Capitalization

$461.05 million

P/E Ratio

45.36

Dividend Yield

N/A

Beta

2.59

Who are the company insiders with the largest holdings of Tectonic Therapeutic?

Tectonic Therapeutic's top insider investors include:
  1. Timothy A Springer (Director)
Learn More about top insider investors at Tectonic Therapeutic.

Who are the major institutional investors of Tectonic Therapeutic?

Tectonic Therapeutic's top institutional investors include:
  1. Farallon Capital Management LLC — 0.96%
  2. Atlas Venture Life Science Advisors LLC — 0.84%
  3. Acadian Asset Management LLC — 0.24%
  4. Renaissance Technologies LLC — 0.20%
  5. Affinity Asset Advisors LLC — 0.13%
Learn More about top institutional investors of Tectonic Therapeutic stock.

Which institutional investors are buying Tectonic Therapeutic stock?

In the previous quarter, TECX stock was acquired by institutional investors including:
  1. Farallon Capital Management LLC
  2. Atlas Venture Life Science Advisors LLC
  3. Acadian Asset Management LLC
  4. Renaissance Technologies LLC
  5. Affinity Asset Advisors LLC